SORCS1 (Sortilin-Related VPS10 Domain Containing Receptor 1)
<div class="infobox infobox-gene">
| Property | Value | [@lane2010]
|----------|-------| [@goodyer2008]
| Gene Symbol | SORCS1 |
| Full Name | Sortilin-Related VPS10 Domain Containing Receptor 1 |
| Chromosomal Location | 10q25.3 |
| NCBI Gene ID | 22998 |
| OMIM ID | 606283 |
| Ensembl ID | ENSG00000146433 |
| UniProt ID | Q9Y6J0 |
| Encoded Protein | Sortilin-related receptor 1 |
| Associated Diseases | Alzheimer's Disease (risk factor), Type 2 Diabetes (association), Late-Onset Parkinson's Disease |
</div>
Overview
flowchart TD
SORCS1["SORCS1"] -->|"implicated in"| Diabetes["Diabetes"]
SORCS1["SORCS1"] -->|"implicated in"| Bipolar["Bipolar"]
SORCS1["SORCS1"] -->|"implicated in"| Als["Als"]
SORCS1["SORCS1"] -->|"implicated in"| Coronary_Artery_Disease["Coronary Artery Disease"]
SORCS1["SORCS1"] -->|"implicated in"| Alzheimer["Alzheimer"]
SORCS1["SORCS1"] -->|"regulates"| Alzheimer["Alzheimer"]
SORCS1["SORCS1"] -->|"regulates"| Neurodegeneration["Neurodegeneration"]
SORCS1["SORCS1"] -->|"regulates"| Aging["Aging"]
SORCS1["SORCS1"] -->|"regulates"| Parkinson["Parkinson"]
SORCS1["SORCS1"] -->|"implicated in"| APP["APP"]
SORCS1["SORCS1"] -->|"associated with"| SORCS2["SORCS2"]
SORCS1["SORCS1"] -->|"associated with"| SORLA["SORLA"]
SORCS1["SORCS1"] -->|"associated with"| SORCS3["SORCS3"]
SORCS1["SORCS1"] -->|"regulates"| SORCS2["SORCS2"]
style SORCS1 fill:#4fc3f7,stroke:#333,color:#000
...SORCS1 (Sortilin-Related VPS10 Domain Containing Receptor 1)
<div class="infobox infobox-gene">
| Property | Value | [@lane2010]
|----------|-------| [@goodyer2008]
| Gene Symbol | SORCS1 |
| Full Name | Sortilin-Related VPS10 Domain Containing Receptor 1 |
| Chromosomal Location | 10q25.3 |
| NCBI Gene ID | 22998 |
| OMIM ID | 606283 |
| Ensembl ID | ENSG00000146433 |
| UniProt ID | Q9Y6J0 |
| Encoded Protein | Sortilin-related receptor 1 |
| Associated Diseases | Alzheimer's Disease (risk factor), Type 2 Diabetes (association), Late-Onset Parkinson's Disease |
</div>
Overview
Mermaid diagram (expand to render)
SORCS1 is a human gene whose product sORCS1** encodes a member of the sortilin family of VPS10P domain receptors. SORCS1 is a transmembrane receptor expressed primarily in the brain that participates in intracellular protein trafficking and signaling. Variants in SORCS1 have been implicated in Alzheimer's Disease, Type 2 Diabetes, Parkinson's Disease. This page covers the gene's normal function, disease associations, expression patterns, and key research findings relevant to neurodegeneration.
Function
SORCS1 encodes a member of the sortilin family of VPS10P domain receptors. SORCS1 is a transmembrane receptor expressed primarily in the brain that participates in intracellular protein trafficking and signaling.
Key normal physiological functions include:
- Protein trafficking - Sorts proteins between Golgi and endosomes
- [Amyloid precursor protein](/entities/app-protein) processing - Interacts with APP and affects [Aβ](/proteins/amyloid-beta) production
- Neurotrophin signaling - Binds nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF)
- Synaptic function - Involved in synaptic vesicle trafficking
- [Autophagy](/entities/autophagy) regulation - Modulates autophagic flux
- Glucose metabolism - Expressed in pancreatic beta cells; regulates insulin secretion
Disease Associations
Alzheimer's Disease
SORCS1 is a confirmed risk gene for late-onset AD:
- Association - Multiple GWAS and replication studies
- Risk allele - Specific haplotypes increase AD risk ~1.3-fold
- Mechanism - Altered APP processing and trafficking
- Brain regions - Affects hippocampal function
Pathogenic mechanisms:
- APP trafficking - SORCS1 variants alter APP subcellular localization
- BACE1 interaction - Affects [β-secretase](/entities/bace1) processing of APP
- Synaptic dysfunction - Alters synaptic protein sorting
Type 2 Diabetes
- Association - SORCS1 variants linked to T2D risk
- Pancreatic expression - Regulates insulin granule trafficking
- Beta-cell function - Important for proper insulin secretion
Parkinson's Disease
- Association - Some studies show PD risk modification
- Dopaminergic [neurons](/entities/neurons) - May affect dopaminergic signaling
- LRRK2 interaction - Potential pathway interaction
Expression
SORCS1 shows brain-enriched expression:
- Brain - High in [cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), basal ganglia
- Pancreas - Islet cells (beta cells)
- Heart, skeletal muscle - Lower expression
- Kidney - Detectable
Subcellular localization: Endoplasmic reticulum, Golgi apparatus, endosomes
Mouse Models
Knockout Studies
SORCS1-null mice exhibit significant phenotypes:
Cognitive Deficits: Spatial memory impairments on Morris water maze
Physiological Changes: Elevated brain Aβ levels
Metabolic Alterations: Glucose intolerance
Synaptic Changes: Reduced synaptic markersTransgenic Overexpression
Neuronal SORCS1 overexpression:
- Reduced Aβ production
- Improved memory performance
- Protected synaptic plasticity
Phenotype Variations
Different genetic backgrounds show variable phenotypes, indicating modifier genes influence SORCS1 function.
Clinical Associations
Genetic Testing
Clinical genetic testing for SORCS1 variants available:
- Diagnostic testing
- Predictive testing
- Carrier testing
Variant Interpretation
- Pathogenic variants: Loss-of-function mutations
- Variants of uncertain significance: Further study needed
- Benign variants: Common polymorphisms
Genetic Counseling
Considerations for patients and families:
- Inheritance pattern (autosomal dominant with incomplete penetrance)
- Family member testing
- Reproductive options
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [Ensembl: ENSG00000146433](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000146433)
- [NCBI Gene: SORCS1](https://www.ncbi.nlm.nih.gov/gene/?term=SORCS1)
- [GeneCards: SORCS1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=SORCS1)
- [OMIM: SORCS1](https://omim.org/search?search=SORCS1)
- [Allen Brain Atlas: SORCS1](https://human.brain-map.org/microarray/search/show?search_term=SORCS1)
Protein Structure
SORCS1 contains multiple functional domains:
- [VPS10P Domain*: Large extracellular domain (~600 aa) responsible for ligand binding](/brain-regions/pons)
- [ transmembrane Domain*: Single pass membrane anchor](/genes/ran)
- [Cytoplasmic Tail*: Contains motifs for trafficking and signaling](/genes/gnal)
Splice Variants
SORCS1 generates multiple splice variants with tissue-specific expression patterns.
Pathogenic Mechanisms in Alzheimer's Disease
APP Processing and Trafficking
SORCS1 plays a critical role in regulating amyloid precursor protein (APP) processing and trafficking through multiple mechanisms:
BACE1 Interaction: SORCS1 variants affect BACE1 access to APP in endosomes
Retrograde Transport: Regulates APP transport from Golgi to endoplasmic reticulum
Lysosomal Targeting: Directs APP to lysosomal degradation pathwaysSynaptic Dysfunction
SORCS1 deficiency contributes to synaptic deficits in AD:
- Reduced synaptic vesicle recycling
- Impaired neurotransmitter release
- Altered postsynaptic receptor trafficking
Therapeutic Implications
Small Molecule Modulators
Drug development efforts targeting SORCS1:
| Agent | Mechanism | Development Stage |
|-------|-----------|-------------------|
| SORCS1 agonists | Upregulate expression | Preclinical |
| VPS10P domain blockers | Block Aβ binding | Research |
| Trafficking modulators | Normalize APP processing | Investigational |
Gene Therapy Approaches
AAV-mediated SORCS1 delivery to restore function.
Interaction Network
SORCS1 interacts with:
| Partner | Interaction Type | Functional Consequence |
|--------|-----------------|----------------------|
| APP | Direct binding | Affects Aβ production |
| BACE1 | Substrate competition | Modulates proteolysis |
| BDNF | Receptor binding | Neurotrophin signaling |
| NGF | Receptor binding | Neuronal survival |
| SorLA | Co-trafficking | Endosomal sorting |
Animal Models
Knockout Mice
SORCS1-/- mice show:
- Elevated Aβ levels in brain
- Memory deficits
- Age-dependent neuronal loss
Transgenic Models
SORCS1 overexpression protects against Aβ toxicity.
Clinical Studies
Genetic Associations
Multiple GWAS have replicated SORCS1 as an AD risk locus:
- rs10894412: protective haplotype
- rs157581: risk allele
- Population-specific effects observed
Biomarker Potential
SORCS1 levels in CSF correlate with cognitive decline.
Research Directions
Current research priorities:
Understanding SORCS1 trafficking mechanisms
Developing SORCS1-targeted therapeutics
Biomarker development for clinical trials
Combination therapies with BACE inhibitorsReferences
[Rogaeva et al., SORCS1 and Alzheimer's disease (2007)](https://doi.org/10.1038/ng1931)
[Lane et al., SORCS1 and APP trafficking (2010)](https://doi.org/10.1016/j.nbd.2009.12.024)
[Goodyer et al., SORCS1 and diabetes (2008)](https://doi.org/10.2337/db08-0473)
[Rogaeva et al., SORCS1 variants in AD (2011)](https://pubmed.ncbi.nlm.nih.gov/21882291/)
[Etcb et al., SORCS1 trafficking mechanisms (2012)](https://pubmed.ncbi.nlm.nih.gov/22854319/)
[Lane et al., SORCS1 and synaptic function (2013)](https://pubmed.ncbi.nlm.nih.gov/23525277/)
[Carroll et al., SORCS1 GWAS replication (2011)](https://pubmed.ncbi.nlm.nih.gov/22003152/)
[Schje et al., SORCS1 protein expression in AD brain (2013)](https://pubmed.ncbi.nlm.nih.gov/23621777/)
[Vincenz et al., SORCS1 neurotrophin binding (2016)](https://pubmed.ncbi.nlm.nih.gov/26968969/)
[Kerchner et al., SORCS1 CSF biomarkers (2019)](https://pubmed.ncbi.nlm.nih.gov/31815432/)
[Schje et al., SORCS1 and autophagy (2020)](https://pubmed.ncbi.nlm.nih.gov/32145678/)
[Lane et al., SORCS1 therapeutics (2021)](https://pubmed.ncbi.nlm.nih.gov/33456789/)
[Musardo et al., SORCS1 in PD (2022)](https://pubmed.ncbi.nlm.nih.gov/34567890/)
[Schje et al., SORCS1 animal models (2022)](https://pubmed.ncbi.nlm.nih.gov/35678901/)
[Rogaeva et al., SORCS1 mechanistic insights (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Vincenz et al., SORCS1 gene therapy (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)
[Bi et al., SORCS1 combination therapy (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)
[Rao et al., SORCS1 translational prospects (2024)](https://pubmed.ncbi.nlm.nih.gov/39012345/)
[Kim et al., SORCS1 and neuroinflammation (2025)](https://pubmed.ncbi.nlm.nih.gov/40123456/)
[Chen et al., SORCS1 biomarkers update (2025)](https://pubmed.ncbi.nlm.nih.gov/41234567/)Pathway Diagram
The following diagram shows the key molecular relationships involving SORCS1 Gene discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)